Probiotic micro-pellets sales will expand through 2036, with capsules at 34.1% of application / dosage form sales, micro-pellets at 35.2% within the pellet type segment and enteric/acid-protective at 36.7% of the coating & function category in 2026. The market is projected to record an 11.3% CAGR between 2026 and 2036.